New blood test aims to predict sepsis in minutes, not hours

NCT ID NCT07425587

Recruiting now Diagnosis Sponsor: Bluejay Diagnostics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether measuring a substance called IL-6 in the blood can quickly predict if an emergency room patient with a suspected infection will develop sepsis or septic shock. Researchers will enroll 450 adults admitted from the ER and track their outcomes for up to 30 days. The goal is to find a cutoff level of IL-6 that reliably identifies those at highest risk, enabling faster, more targeted care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: IL-6 blood test
What this could lead to: If successful, this could provide a rapid, reliable way to identify sepsis early in the emergency room, potentially saving lives by speeding up treatment.
What could go wrong: This is an early pilot study, so the test may not prove accurate enough. It also only measures one marker, which might miss some cases of sepsis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS, SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies Infections infectious disease with sepsis Inflammation Pathologic Processes Sepsis Shock Systemic Inflammatory Response Syndrome toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS, SEPTIC SHOCK

Contacts and locations

Show contact details

Locations

Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02215, United States
Intermountain Health
RECRUITING

Salt Lake City, Utah, 84111, United States

Contact Email: •••••@•••••
University of Florida College of Medicine
RECRUITING

Gainesville, Florida, 32610, United States
Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

Contact Email: •••••@•••••
Wake Forest School of Medicine
RECRUITING

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.